Proteasome InhibitorsBoronic AcidsPyrazinesProteasome Endopeptidase ComplexLeupeptinsProtease InhibitorsCysteine Proteinase InhibitorsCysteine EndopeptidasesMultienzyme ComplexesMultiple MyelomaAntineoplastic AgentsAcetylcysteineApoptosisCell Line, TumorUbiquitinsUbiquitinDrug SynergismOligopeptidesLactonesUbiquitinationNF-kappa BDrug Resistance, NeoplasmProteolysisThalidomideDose-Response Relationship, DrugCell LineTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsXenograft Model Antitumor AssaysBlotting, WesternUbiquitinated ProteinsThiostreptonDown-RegulationEnzyme InhibitorsTumor Cells, CulturedLymphoma, Mantle-CellCell SurvivalCaspasesPeptide HydrolasesPolyubiquitinChymotrypsinProto-Oncogene Proteins c-bcl-2Ubiquitin-Protein LigasesSignal TransductionDexamethasoneEndoplasmic ReticulumTime FactorsCell ProliferationI-kappa B ProteinsRNA, Small InterferingMyeloid Cell Leukemia Sequence 1 ProteinDrug Screening Assays, AntitumorCells, CulturedImmunoblottingProtein Processing, Post-TranslationalProtein SubunitsHeLa CellsCell DeathTransfectionEnzyme ActivationNeoplasmsPyrrolesPhosphorylationUnfolded Protein ResponseHydroxamic AcidsCell CycleTNF-Related Apoptosis-Inducing LigandDrug Administration ScheduleApoptosis Regulatory ProteinsRNA, MessengerProtein BindingCaspase 3ClioquinolAutophagyMice, NudeTumor Suppressor Protein p53Ubiquitin-Activating EnzymesMice, SCIDMaximum Tolerated DoseLactams, MacrocyclicMolecular Sequence DataInhibitory Concentration 50Histone Deacetylase InhibitorsMutationCyclin-Dependent Kinase Inhibitor p27BenzoquinonesUbiquitin-Conjugating EnzymesAmino Acid SequenceHSP90 Heat-Shock ProteinsProtein TransportProtein StabilityReverse Transcriptase Polymerase Chain ReactionPeripheral Nervous System DiseasesNeoplasm ProteinsDrug Evaluation, Preclinical1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltUp-RegulationDoxorubicinModels, BiologicalRecurrence